Interactions between metabolism and circadian clocks: reciprocal disturbances. by Delezie, J. (Julien) & Challet, E. (Etienne)
Ann. N.Y. Acad. Sci. ISSN 0077-8923
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
Issue: The Year in Diabetes and Obesity
Interactions between metabolism and circadian clocks:
reciprocal disturbances
Julien Delezie and Etienne Challet
Department of Neurobiology of Rhythms, Institute of Cellular and Integrative Neurosciences, Centre National de la Recherche
Scientifique, UPR3212 associated with University of Strasbourg, Strasbourg, France
Address for correspondence: Etienne Challet, CNRS and University of Strasbourg, Institute of Cellular and Integrative
Neurosciences, 5 rue Blaise Pascal, Strasbourg, FR 67000, France. challet@inci-cnrs.unistra.fr
Obesity is a medical condition of excess body fat, recognized as a global epidemic. Besides genetic factors, overcon-
sumption of high-energy food and a sedentary lifestyle are major obesogenic causes. A newly identified determinant
is altered circadian rhythmicity. To anticipate and adapt to daily changes in the environment, organisms have de-
veloped an endogenous circadian timing system, comprising a main circadian clock, located in the suprachiasmatic
nucleus (SCN) of the hypothalamus, principally synchronized to the light–dark cycle. Secondary peripheral clocks
are found in various tissues, such as the liver, pancreas, and adipose tissue. These clocks control the rhythmic patterns
of myriad metabolic processes. We will review the evidence that metabolic dysfunction is associated with circadian
disturbances at both central and peripheral levels and, conversely, that disruption of circadian clock functioning
can lead to obesity. The roots of these reciprocal interactions will be illustrated by transcriptional crosstalk between
metabolic and circadian systems. Chronotherapeutic approaches of dieting to maintain or restore a proper circadian
alignment could be useful to limit the magnitude of metabolic risks.
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Introduction
Over recent decades, obesity has become a major
health problem, while at the same time being one
of the leading preventable causes of death in the
world.1 Obesity is a pathological condition defined
as excessive fat accumulation and is associated with
major complications, such as diabetes, hyperten-
sion, and cardiovascular diseases. Besides a few ge-
netic factors, the main contributor to obesity is an
overconsumption of food that is high in calories and
saturated fat. In addition to high-fat, hypercaloric
diets, sedentary lifestyles have supplanted regular
physical activity, resulting in a positive energy bal-
ance (more energy intake, less energy expenditure)
and obesity.2
Along with these factors, timing aspects of food
intake and metabolic regulation have to be taken
into consideration. In living organisms, most essen-
tial biological functions show a rhythmic pattern
close to 24 hours. These endogenous daily varia-
tions, called circadian rhythms (from the latin: circa
meaning about and diesmeaning day), allow organ-
isms to anticipate and prepare for periodic changes
in the environment (e.g., light–dark cycle or food
availability). The timing anddurationofmanyphys-
iological, metabolic, and behavioral processes are
therefore dictated by a circadian timing system in
coordination with the environment.
After a brief introduction of the circadian tim-
ing system, we will review the literature showing
that the occurrence of obesity and/or diabetes is as-
sociated with circadian disturbances. Next, we will
present laboratory studies demonstrating that di-
rect circadian disruptions can have a broad im-
pact on metabolism. We will also highlight the
fact that irregular mealtimes and/or unusual light-
ing conditions are major contributors of circadian
misalignment, perturbing both clock rhythmicity
and metabolic homeostasis. By a reinforcing effect,
circadian misalignment, resulting from inappro-
priate timing of food intake and/or exposure to
doi: 10.1111/j.1749-6632.2011.06246.x
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Figure 1. Organization of the circadian timing system. The master clock, located in the suprachiamatic nuclei (SCN) of the
hypothalamus, adjusts the timing of many secondary clocks/oscillators in the brain and peripheral organs, in part via nervous
pathways (dotted red lines). Light perceived by the retina is the most potent synchronizer of the SCN clock (dashed yellow arrow),
while meal time can synchronize peripheral clocks (blue arrows).
unusual sleep/wake cycles, increases the likelihood
of metabolic risk factors, and can even lead to
metabolic disruptions. Finally, we will illustrate the
transcriptional interactions between metabolism
and the circadian system, and their importance in
the development of overweight.
The circadian metabolism
The circadian timing system: an overview
In mammals, the circadian timing system is com-
posed of several endogenous clocks, allowing bio-
logical functions to oscillate and be in phase with
daily changes in the environment. The main cir-
cadian clock is located in the SCN of the anterior
hypothalamus. The SCN is composed of multiple
coupled cellular clocks that can generate circadian
oscillations.3 For a proper phase adjustment of the
circadian timing system to the external environ-
ment, SCN neurons receive direct input from the
retina in order to be synchronized (i.e., reset) to the
24-h light–dark cycle.4 When light activates pho-
toreceptors, in particular the intrinsically photo-
sensitive retinal ganglion cells, nerve impulses are
conducted directly through the retinohypothalamic
tract to the SCN.5 As a result, the synchronized
SCN orchestrates the rhythmicity of many aspects
of metabolism, physiology, and behavior via neu-
ronal connections and humoral factors, with a 24-h
period (Fig. 1).
The functioning of a circadian clock is depen-
dent on a core clock mechanism involving spe-
cific genes called “clock genes.” Among them pe-
riod homolog 1–3 (Per1, Per2, Per3), cryptochrome
1,2 (Cry1, Cry2), circadian locomotor output cy-
cles kaput (Clock) or its analog neuronal PAS do-
main protein 2 (Npas2), brain and muscle Arnt-
like 1 (Bmal1), reverse viral erythroblastis onco-
gene products (Rev-erba andRev-erbb), and retinoic
acid-related orphan receptors (Rora, Rorb, Rorg) are
essential.6 Clock genes are coexpressed (in virtually
all tissues) and their products reciprocally interact
at the transcriptional/translational levels to gener-
ate circadian oscillations. At least three autoregula-
tory feedback loops are interconnected: one positive
in which CLOCK and BMAL1 dimerize to activate
the E-box-mediated transcription of Per and Cry
genes; one negative whereby upon reaching a criti-
cal concentration, PER and CRY proteins enter into
the nucleus to inhibit the transactivation mediated
by CLOCK:BMAL1, therefore inhibiting their own
transcription; andan interconnecting loop, inwhich
Rors can activate the transcription of Bmal1 and
Npas2, whereas Rev-erbs can repress Bmal1, Clock,
andNpas2, via retinoic acid-related orphan receptor
response element (RORE) (Fig. 2).7–10 This loop en-
sures the fine tuning of circadian rhythms. In addi-
tion, posttranslational mechanisms such as protein
phosphorylation, affect stabilization, degradation,
and subcellular localization of clock proteins, thus
contributing to the molecular clockwork.11
Circadian control of metabolic functions
A few hypothalamic nuclei, including the paraven-
tricularnucleus, receivedirectneuronal connections
from the SCN12,13 and project to peripheral tis-
sues, such as the liver,14,15 pancreas,16 or adipose
tissue17 via autonomic output pathways. Consider-
able experimental work has highlighted the impor-
tant role of hypothalamic nuclei in the control of
feeding and energy metabolism. The ventromedial
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Figure 2. Simplified cellular model of the mammalian molecular clockwork. Circadian rhythms are generated by transcrip-
tional/translational feedback regulatory loops of core clock genes. CLOCK (or NPAS2) and BMAL1 can dimerize to rhythmically
transactivate genes containing a specific DNA sequence (E-box) in their promoter region. As a result, the transcriptional activity of
Pers, Crys, Rors, and Rev-erbs is enhanced, and their products from translational activity are cyclically released in the cytoplasm.
Then, when PERs and CRYs proteins reach a critical concentration, they form heterodimers that translocate into the nucleus to
repress transcriptional activity induced by CLOCK (NPAS2):BMAL1, leading to their own repression. An additional loop involves
the nuclear receptorsRev-erbs and Rors, which can translocate into the nucleus to modulate Bmal1, Clock, andNpas2 transcription
via opposite action on a RORE sequence located in their promoter.
hypothalamic nucleus, lateral hypothalamus, and
arcuate nucleus (ARC) contain glucose-sensing
neurons and receive nutritional information from
blood-borne signals and neuronal messages from
brainstem nuclei, including parabrachial nucleus
and nucleus of the solitary tract (NTS). Among the
key hormones that modulate feeding via hypotha-
lamic activity, leptin synthesized by adipocytes acts
on ARC, in particular, to inhibit appetite and stim-
ulate energy expenditure.18 Insulin, released from
the  cells of the pancreas, also has anorexigenic ef-
fects on themetabolic hypothalamus.19 On theother
hand, ghrelin, released by the stomach, activates
neuropeptide Y/Agouti-related peptide-containing
neurons in the ARC to increase appetite and de-
crease energy expenditure.20 An important role of
the SCN is to orchestrate the internal ticking of dif-
ferent central andperipheral tissues.Therefore, 24-h
rhythmic patterns can be observed for a plethora
of metabolic functions, such as glucose,21,22
nonesterified fatty acids (NEFA), insulin,22 and lep-
tin levels.23
The clock genes mentioned above are not only
expressed in the SCN, but also in other brain re-
gions and peripheral tissues.24–26 In the liver, clock
genes show a robust circadian pattern of expres-
sion.25 In rats, destruction of the SCN abolishes the
circadian rhythm of food intake.27 SCN lesions do
not abolish Per2 rhythms in peripheral tissues, but
produce internal desynchrony.28 Microarray anal-
ysis of the mouse liver transcriptome showed that
9% of more than 2,000 genes studied oscillate in
a circadian manner and may be under the con-
trol of the SCN.29 Thus, it is likely that the SCN
modulates both behavior and metabolism by ad-
justing the phase of peripheral oscillators. Recent
genome-wide transcriptome analyses performed in
the SCN, liver, and adrenal glands of mice, revealed
that around 10% of transcripts are regulated in a
circadian manner.30–35 Of the 49 nuclear receptors
that are key actors of metabolic regulations (see be-
low), approximately 40% were cyclic in the liver or
white adipose tissue (WAT).36 Liver posttranscrip-
tional and translational mechanisms contribute as
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well to circadian coordination.37 While the master
clock in the SCN is mainly synchronized by light,
clock gene oscillations in peripheral tissues can be
shifted by feeding time (Fig. 1).25,38,39 In contrast,
the SCN clock is relatively impervious to the syn-
chronizing effect of meal time, provided that the
animals are exposed to a light–dark cycle and ingest
enough daily energy. Under severe food restriction
(i.e., caloric restriction), however, the phase of the
SCN and its synchronization to light aremodified.40
Expression in theSCNof receptors tometabolic hor-
mones (i.e., insulin, ghrelin, and leptin) raises the
possibility that peripheral hormonal signals can feed
back to the SCN.41–43
Therefore, the whole circadian system partici-
pates in the daily variation of metabolism. Several
biological approaches andgeneticmodelshavegiven
further insight into the maintenance of metabolic
homeostasis and the crosstalk between the circadian
system andmetabolism, as will be further discussed
below.
Metabolic diseases are associated
with circadian disturbances
Genetic obesity and diabetes
Monogenic causes of obesity and diabetes are rela-
tively rare, especially in humans. For instance, early-
onset obesity has been associated with a mutation
in the leptin receptor in humans.44 In rodents, how-
ever, genetic syndromes of obesity and diabetesmel-
litus offer models of choice to analyze circadian dis-
turbances associated with metabolic physiopathol-
ogy.
In obese Zucker rats, which carry amutation (i.e.,
fa) in the leptin receptor gene, daily rhythms of lo-
comotor activity, body temperature, and feeding are
phase advanced (i.e., the active phase starts in the
afternoon in contrast to the nocturnal onset in +/?
littermates) and their day–night amplitude is gener-
ally reduced.45–47 Increased daytime feeding is also
observed in obese mice carrying the null mutation
of a receptor to prostaglandin E2 (i.e., EP3 sub-
type).48 As a rule, the amplitude of the sleep–wake
cycle and activity–rest rhythm is dampened in ge-
netically obese rats andmice, diabetic or not, due in
part to increased wake/activity during daytime and
increased sleep at night.49–54
The molecular clockwork in peripheral tissues is
consistently disrupted in genetically obese, diabetic
or not, mice. More precisely, in obese ob/ob and
KK mice as well as in obese and diabetic KK-AY
mice, the amplitude of daily profiles of clock gene
expression in the liver or white adipose tissue is
generally reduced, if not barely sizeable.55,56 In the
liver of obese anddiabetic db/dbmice, themolecular
clockwork is differentiallymodified according to the
clock gene considered.51
Of interest, in ob/ob mice, alterations in periph-
eral clocks occur earlier than metabolic symptoms,
such as morbid obesity and hyperinsulinemia, thus
suggesting that altered clockwork can play a role in
obesity in addition to the specific deficiency of lep-
tin.55 Within the central nervous system of ob/ob or
KK-AY mice, clock gene oscillations have been stud-
ied in the NTS. The most salient changes concern
Bmal1 and Rev-erba, whose daily expression is up-
and downregulated, respectively.57 Moreover, the
molecular clockwork of the SCN is notmarkedly af-
fected in leptin-deficient, obese (i.e., ob/ob) mice.55
Unexpectedly in view of the severe dampening of
overt rhythmicity in db/db mice, the amplitude of
SCNmolecular oscillations is significantly increased
in these mice compared to db/+ littermates.51 Fi-
nally, it is worth mentioning that ob/ob mice show
increased photic resetting of the master clock.54
Diet-induced obesity
In nature, species are not often confronted with
food abundance. On the contrary, food can be rare
for most animals and foraging is a key for survival
(thus contributing to energy expenditure). Conse-
quently, obese animals in the wild are uncommon,
except for some species in which overweighting is
important to support long periods of fasting (e.g.,
penguins, bears), and those species living in prox-
imity to humans and consuming greasy food that
is discarded by people. Most laboratory-based re-
search on obesity is carried out in rodents.58 Con-
trol animals usually have an ad libitum access to
a normocaloric chow diet. Despite this free access,
most rodents regulate their consumption and the
time when they eat and do not become obese.
Obesity can be induced by feeding rodents on an
ad libitum basis with a high-fat diet (HFD, more
than 50% of metabolizable energy derived from
fat). Both the amount and dietary fat type alter
body mass and composition.59 Short-term high-fat
feeding reduces circadian variations of leptin lev-
els in rats60 and humans,61 thus suggesting that
dampened circulating leptin could contribute to the
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development of obesity. In mice, high-fat feeding
attenuates the daily pattern of food intake, with a
higher consumption during the day and a concomi-
tant decrease during the active period, before sig-
nificant mass gain. In WAT of mice fed with HDF,
expression ofmetabolic genes can be downregulated
at night, such as sterol regulatory element-binding
protein 1c (Srebp-1c) or fatty-acid binding protein
4 (Fabp4), while expression of others is barely af-
fected, like acetyl-CoA carboxylase (Acc) and fatty
acid synthase (Fas). Other transcriptional changes
are detected in the liver of these mice: expression
of Acc, Fas, and Fabp1 is upregulated, while the
nighttime peak of Srebp-1c is phase-advanced to
the afternoon. Moreover, changes in the concentra-
tion and temporal pattern of expression of glucose,
insulin, leptin, andNEFA are also observed.62 High-
fat feeding also leads to difficulties in maintaining
wakefulness during the active period and increases
nonrapid eye movement sleep in mice63 as well as
postprandial sleepiness inhumans,64 suggesting that
the metabolic state affects neural structures regulat-
ing sleep. Equally interesting, HFD seems to have a
direct effect on the main circadian clock. In mice,
HFD lengthens the free-running period62 and dis-
rupts photic synchronization of the SCN to light, as
shown by slower re-entrainment to shifted light–
dark cycle and reduction in light-induced phase
shifts.65 There is also a clear change in neuropep-
tide expression in the mediobasal hypothalamus,
despite nomajormodification of the core clockma-
chinery in that region.62 In the brainstem, more
precisely in the NTS, mice fed with HFD display
altered daily patterns of clock gene expression, in-
cluding downregulated Rev-erba, and upregulated
Bmal1 and Clock mRNA levels.57 Taken together,
these results suggest that central dysfunctions may
contribute to the development of obesity.
Oscillations of clock genes have been found in
human WAT,66 but no difference has been detected
in the characteristics of these oscillations between
lean, overweight, anddiabetic individuals.67 By con-
trast, the circadian timing of peripheral tissues is
markedly modified by fat overload in rodents. HFD
alters the diurnal variation in glucose tolerance, and
insulin sensitivity by influencing clock function-
ing.68 In the liver, changes are seen in the level as
well as the rhythmic patternofmajor components of
lipid homeostasis and adiponectin metabolic path-
way, with parallel modifications in clock gene ex-
pression.62,69 In HFD-fed animals, expression of
metabolic actors is asynchronous in liver and adi-
pose tissue, suggesting the importance of tempo-
ral coordination among metabolic tissues. Further-
more, HFD also attenuates the amplitude of Clock,
Bmal1, and Per2 in adipose tissue.62 Hence, al-
tered circadian clock function within adipose tissue
may promote excess fat storage (especially intra-
abdominal fat). However, it is important to note
that HFD-induced changes in clock gene expression
could be gender specific, since a recent study in fe-
male mice did not obtain the same results. Indeed,
eight weeks of HFD had only mild effects on clock
gene profiles in the liver and adipose tissue, in spite
of the presence of hyperlipidemia, hyperglycemia,
and overweight.70 Moreover, the time and duration
of feeding are also important. Four or eight weeks
of HFD failed to alter peripheral clocks, whereas
11 weeks did.70,71 The differences between strains,
gender, starting age of HFD feeding, and its du-
ration, add a level of complexity to the compre-
hension of the risk factors that trigger obesity in
rodents.
In summary, impairment of clock gene oscil-
lations and metabolic pathways may explain the
altered coordination of metabolic functions and
clock-controlled output signaling, contributing to
obesity and associateddisorders (e.g., diabetes, sleep
disturbances). Recent evidence also demonstrates
that disruption of the circadian timing system solely,
has various consequences on metabolism.
Circadian disruption is associated with
metabolic dysfunctions
Altered endogenous clockwork
As aforementioned, clock genes are expressed in vir-
tually all tissues and circadian clocks participate in
the daily regulation of metabolic functions such as
glucose and lipid metabolism.22,68
One of the first clock genes studied was Clock.
Homozygous C57BL/6J Clock mutant mice are hy-
perphagic, show a dampened feeding pattern, with
increased food intake during the rest period, and
attenuated energy expenditure at night, thus con-
tributing to fat excess. Clock mutant mice display
severemetabolic alterations, including hypercholes-
teronemia, hypertriglyceridemia, hepatic steatosis,
and hyperglycemia. In addition, Clock mutation
leads to day–night changes in the expression of
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hypothalamic neuropeptides, like CART (Cocaine
and amphetamine regulated transcript) and orexin
mRNA, which play a role in central circuits control-
ling feeding and arousal.72 Furthermore, Clock mu-
tation induces profound changes in glucose home-
ostasis, such as increased insulin sensitivity and al-
tered gluconeogenesis.68 Of interest, in the liver,
Clock has been shown to directly drive the expres-
sion of glycogen synthase 2 gene via E-boxes.73 In
Clockmutantmice generated on aCBA/6CaHback-
ground (which synthesize melatonin contrary to
the C57BL/6J strain), impairments in glucose tol-
erance, insulin secretion, liver Pepck mRNA expres-
sion, and increased insulin sensitivity are also ob-
served, although these mice do not become spon-
taneously obese unlike C57BL/6J Clock mutants.74
Moreover, Clock (Jcl:ICR) mutant mice display lev-
els of triglycerides and NEFA lower than control
mice, and cholesterol and glucose levels do not dif-
fer. Due to reduced lipid absorption and hepatic
lipogenesis, these mice challenged with HFD show
reducedbodymass elevation, leptin, and insulin lev-
els.75,76 In spite of these discrepancies, due notably
to strain-related differences, mutation of the Clock
gene clearly has an impact on lipid metabolism,
since Clock has been shown to participate in liver
cholesterol accumulation77 and to amplify obesity
in ob/ob mice.78
Bmal1, a close partner of Clock, has been shown
to participate in adipocyte differentiation and li-
pogenesis.79 Sensitivity to exogenous insulin is in-
creased by deletion of Bmal1, while gluconeogene-
sis is suppressed.68 Liver-specific deletion of Bmal1
in mice nicely confirmed its strong involvement
in glucose metabolism. L-Bmal1−/− mice have im-
paired expression of clock-related genes involved
in hepatic glucose regulation such as genes encod-
ing glucose transporter 2, glucokinase, or pyru-
vate kinase. L-Bmal1−/− mice were hypoglycemic
during the resting period, were more glucose tol-
erant, had normal insulin sensitivity and produc-
tion, and normal total body fat content com-
pared to wild-type mice.80 Altogether, these re-
sults demonstrate that Clock and Bmal1 modulate
hepatic function to regulate glucose and fatty acid
homeostasis. Interestingly, two Bmal1 haplotypes
have been associated with diabetes in humans81 as
well as Clock polymorphisms and related haplo-
types that may play a role in the development of
obesity.82,83
Recent elegant studies have explored the role of
Clock and Bmal1 in the pancreatic islets, demon-
strating that the pancreas harbors a functional cir-
cadian oscillator.84,85 They showed that pancreas-
specific Bmal1 mutant mice have higher blood glu-
cose levels during the whole 24-h cycle, impaired
glucose tolerance, and reduced insulin secretion.
Moreover, pancreatic islets of these mutant mice
have altered development and produced less insulin,
suggesting that intact clock functioning in the pan-
creas is essential for normal insulin secretion.85 This
study establishes clearly that circadian components
can regulate local metabolism.
Mutation of the core clock gene Per2 can also lead
to abnormal conditions. In Per2−/– (Per2tm1Brd)
mice, daily corticosterone rhythm is markedly at-
tenuated. Of interest, when fed with HFD, these
mice eat more during the rest period compared to
wild-type mice and develop obesity.86 Moreover,
the rhythmic pattern in Per2−/– mice of alpha-
melanocyte-stimulatinghormone (-MSH), apow-
erful appetite suppressing peptide, is disrupted
and peripheral injection of -MSH induces weight
loss.86 Interestingly, the circadian rhythm of Per2
was dampened in the mediobasal hypothalamus of
Clock mutant mice that are obese.72 In mice in
which Per2 is fully ablated, lipid metabolism was
altered with decreases in both plasma NEFA and
total triacylglycerol (TAG), and TAG contents in
the WAT.87 In Per2−/− mice, and to a lesser extent
in Per1−/− mice, glucose tolerance was increased
(i.e., improved) compared to wild-type animals.88
By contrast, in Per1−/− and Per2−/− double-mutant
mice (129/sv background), glucose tolerance and
insulin sensitivity were both attenuated.80 Triple-
mutant mice for Per1-Per2-Per3 gain more body
mass on HFD than wild-type mice, similar to Per3
single-mutant mice, thus indicating that the Per3
mutation alone accounts for the obese phenotype.89
Alongwith core clock components, secondary ac-
tors of circadian oscillations take part in metabolic
functions. Rora, activator of Bmal1 transcription,
has been shown to participate in the regulation of
apolipoprotein C-III (Apo C-III) gene involved in
triglyceride metabolism,90 and lipid homeostasis in
skeletal muscle.91 Rev-erba, repressor of Bmal1, is
involved in adipocyte differentiation92,93 and rhyth-
mic bile and lipid homeostasis.94 Rev-erba−/− mice
displayed elevated serumApoC-III and triglycerides
levels.95 Moreover, although thedeletionofRev-erba
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alone has only aminor effect on hepatic glucose reg-
ulation,94 the alterations aremore pronounced with
concomitantmutationofPer2.96 Indeed, the expres-
sion of key enzymes of glucose metabolism, such
as glucose-6-phosphatase or glucokinase, was more
affected in the liver of Rev-erba−/−/Per2 mutant
mice.
From all these results, it is tempting to think that
studying the effects of clock gene disruption could
shed light on the incapacity of physiological control
mechanisms to cope with adverse consequences, for
instance of overweight.However, the effects of amu-
tation in theNocturnin gene, which encodes a circa-
dian deadenylase important for posttranscriptional
regulation of circadian-related genes,97 do not fit
with this thought.Nocturnin knockout mice exhibit
no change in circadian rhythmof locomotor activity
and liver clock gene expression, although they have
altered expression of metabolic genes, reduced lipid
absorption, and are resistant to diet-induced obe-
sity. This study indicates that circadian metabolism
can be disrupted without noteworthy modification
in core clock functioning while a specific subset
of circadian downstream targets involved in lipid
metabolism is affected.98 Ongoing research into the
complex crosstalk between components of the circa-
dian system andmetabolismmay lead to prevention
and improve treatment ofmetabolic disorders in the
future.
Altered rhythmic “environment”
There are two main external causes of disruption
in circadian rhythmicity. The first one concerns
chronic changes in timing of light–dark cycles, such
as chronic jet lag. The second way relates to be-
havioral activity (e.g., physical activity, feeding) oc-
curring during the usual resting period (nighttime
in humans, daytime in nocturnal rodents) with
long-term shifts, such as during night work (also
called permanent shift work), or short-term shifts,
like rotating shift work. As detailed below, these
desynchronizing situations have deleterious conse-
quences on circadian organization and metabolic
health.
Housing mice in light–dark cycles that are too
short (i.e., 20 h) for enabling daily synchroniza-
tion of their master clock leads to larger body mass
gain and increased insulin/glucose ratio, indicative
in the fasted state of insulin resistance.99 The same
paradigm has also been shown to aggravate car-
diovascular disease in mice.100 In human subjects
exposed to controlled 28-h sleep–wake cycles un-
der dim light (so-called “forced desynchronization”
protocol), circadian misalignment impairs glucose
tolerance and reduces sensitivity to insulin.101 Ad-
ditionally, constant exposure of mice to bright or
dim light leads to increased body mass and reduced
glucose tolerance compared to mice housed under
a regular light–dark cycle.102
Repeated weekly shifts of 24-h light–dark cycle
in rats fed with regular chow diet lead to chronic
desynchronization and trigger higher body mass
gain103 as well as impaired insulin regulation.104 In-
terestingly, expression of FABP4 is upregulated in
WATof rats exposed to repeated light–dark shifts.105
A number of epidemiological studies in differ-
ent countries have highlighted increased metabolic
risks for cardio-metabolic syndrome, including in-
creased disturbances in lipid metabolism (e.g., high
levels of cholesterol and triglycerides),106–110 glu-
cose metabolism (e.g., high fasting insulin and glu-
cose),108,111 increased concentration of leucocytes,
reflecting systemic inflammation,108 and hyperten-
sion.106,110
Chronic sleep disturbance or sleep restriction un-
der a regular light–dark cycle alters glucose home-
ostasis in rats.112 In humans, recurrent sleep debt
is a newly identified risk factor for obesity and dia-
betes,113,114 indicating that it is likely an aggravating
factor for metabolic disturbances in night workers.
Being nocturnal animals, laboratory rats and
mice exposed to a light–dark cycle consume most
of their daily food during the night period. In ro-
dents, daytime feeding is a potent synchronizer of
peripheral clocks.25,38,39,115 Access to food restricted
to a few hours during the light phase usually leads
to mild body mass loss or no change at all.38,116,117
In more rare cases, food-restricted rats with chow
diet available only for a few hours can increase their
bodymass.118 A clear contribution of circadian tim-
ing of food intake in bodymass gain has been shown
in Zucker rats (Fig. 3).46 As mentioned above, fa/fa
rats ingest a larger proportion of food during the
usual resting phase (i.e., light phase) than control
animals. This study was the first to demonstrate
that by limiting food access to the normal period
of activity and feeding (i.e., nighttime in nocturnal
rats), Zucker rats gained less body mass compared
to free-fed animals, in spite of similar amounts of
food intake between both groups.46 More recent
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Figure 3. Importance of feeding time in genetic or diet-induced obesity. In Zucker rats (upper panels), obese individuals (i.e.,
fa/fa; blue lines and bars) eat more during daytime than control littermates (+/?; red lines and bars). When food access is limited
to nighttime (orange lines and bars), fa/fa rats gain less body mass in spite of similar whole energy intake compared to free-fed
individuals (modified with permission from Ref. 46). In C57BL6mice (lower panels), free access to a high-fat diet is associated with
an increase in daytime feeding (purple line), while chow feeding is mostly nocturnal (red line). If high-fat feeding is restricted to
daytime or nighttime hours (light and dark purple bars, respectively), body mass gain is larger in the former, despite comparable
energy intake (drawn from data in Refs. 62 and 118).
observations confirm nicely the metabolic conse-
quences of unusual timing of feeding. Mice fed ad
libitum with HFD display a rapid increase in day-
time feeding that takes place weeks before the obese
phenotype is detectable.62 Furthermore, whenHFD
was restricted to the light phase, mice gained more
body mass than those on the same diet but with
access limited to the dark phase (Fig. 3).119
Another paradigmused to awaken rodents during
their resting period (i.e., daytime) is forced activity
that leads to internal desynchronization.120 Keeping
food intake to the normal feeding period (i.e., night)
in spite of diurnal forced activity prevents bodymass
and metabolic changes.121 Considering that expo-
sure to bright light at night is an aggravating factor
for the occurrence of pathologies in human night
workers,122 it may be clinically relevant to develop
shift-work models in day-active animals.
In humans, night-eating syndrome (NES) is char-
acterized by a delayed pattern of calorie intake
(i.e., lack of appetite in the morning and evening
or nocturnal hyperphagia). In contrast to this de-
layedmeal timing, the daily rhythm of plasma ghre-
lin is largely phase advanced, while the rhythm in
plasma glucose is phase opposed in patients with
NES compared to those in control subjects.123 El-
evated nocturnal, but not “evening,” feeding has
been correlated with an increased risk of over-
weight in some,124,125 but not all epidemiological
studies.126
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As aforementioned, a set of clock genes is respon-
sible for the generation of circadian oscillations.
From genetic strategies allowing modifications of
the genome in mice, it has been discussed above
that most, if not all, clock gene deletions lead to a
broad range of metabolic diseases. In addition, we
have introduced the effects of unhealthy food and
incorrect timing of food intake on metabolic regu-
latory centers and the core clock machinery. In this
last section, we will give an overview of the emer-
gent understanding of the communication within
the circadian clock circuitry. We will illustrate the
differentmolecular pathways bywhich clock-related
nuclear receptors are involved in metabolism and
the effects of nutrient “sensors” on core clock com-
ponents (Fig. 4).
The nuclear receptors’ dynamic network
Transcriptomal analyses have demonstrated that a
large number of nuclear receptors are expressed in a
circadian manner.36 Among them, Rors, Rev-erbs,
and peroxisome proliferator-activated receptor
(Ppars) genes appear to be pivotal players at
the interface between the circadian system and
metabolism.127
Figure 4. A schematic illustration of the cross-talk between circadian components and metabolic regulators. The master clock
housed in the SCN is connected to several brain and peripheral clocks to orchestrate rhythmic activities. All clocks share a com-
mon molecular mechanism in which the clock genes are coexpressed, and the generation of circadian oscillations is made from
transcriptional/translational interactions (represented in the gray box; for more details, see Fig. 2). Clock genes can influence,
directly or indirectly, the rhythmic expression of many metabolic genes (listed in the blue box). Clock components can also control
rate-limiting enzymes in the NAD+ salvage pathway (i.e., Nampt) and heme biosynthesis (i.e., Alas1). Intracellular metabolism
through the action of SIRT1, AMPK, and heme can impinge both metabolic genes and core clock machinery. In addition, epige-
netic modifiers, such as HDAC3 recruited by REV-ERB via NCoR1, modulate clock and metabolic gene transcription (orange
box).
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As introduced above, RORs and REV-ERBs com-
pete for binding RORE in clock gene promoters.7–10
Interestingly, Rev-erba can repress its own tran-
scription on a functional REV-ERB binding site
(RevDR2) located in its promoter.128 ROR being
able to bind to this site participates in the control of
Rev-erba transcription.129 Hence, genes containing
either RORE or RevDR2 in their promoter are acti-
vated by ROR and repressed by REV-ERB. This
highlights the occurrence of dynamic interactions
within the core clock machinery. In skeletal muscle,
Rora directly regulates themouse caveolin-3 (Cav-3)
and carnitine palmitoyltransferase-1 (Cpt1) genes,
involved in fatty acid metabolism.91 Rora also en-
hances activity of the human Apo C-III gene pro-
moter90 and binds to the rodent apolipoprotein A-I
(ApoA1) RORE.130 Additional evidence for a role
of Rora in metabolism is provided by the fact that
cholesterol is a putative ligand of ROR.131
Numerous studies have shown that REV-ERBs
also influence lipid and energy homeostasis. The
expression of a dominant negative version of Rev-
erbb in transfected cell lines attenuates expression of
genes involved in lipid metabolism, such as Fabp3-
4, cluster of differentiation 36 (Cd36), stearoyl-
coenzymeA desaturase 1 (Scd1), and cellular energy
balance (e.g., uncoupling protein 3, Ucp3). Simi-
larly to Rora, Rev-erba can bind directly to the hu-
man Apo C-III promoter95 and the rat Apoa-I pro-
moter RORE.132 For the repressive action on Bmal1
transcription, Rev-erba has been shown to recruit
the nuclear receptor corepressor (NCoR)/histone
deacetylase 3 (HDAC3) complex.133 Of interest,
genetic disruption of NCoR1-HDAC3 interaction
in mice induces changes in Bmal1 expression and
circadian behavior with concomitant effects on
metabolism (e.g., increased insulin sensitivity, al-
tered expression of metabolic genes). Surprisingly,
loss of a functional NCoR1-HDAC3 complex also
protects mice from diet-induced obesity.134 On the
other hand, a recent study has explored the role of
the circadian genomic recruitment of HDAC3 in
the mouse liver. They showed that REV-ERB con-
trols the circadian expression of lipid metabolism
genes by recruiting the repressive chromatin modi-
fier HDAC3 (and NCoR) to the genome during the
light period, therefore preventing lipogenesis at a
time when animals are resting. In addition, deletion
of eitherHdac3 orRev-erba results in hepatic steato-
sis indicating steady lipogenesis.135 These findings
demonstrate that the circadian control of epigenetic
modifiers by clock components is critical for normal
metabolic processing. Additional evidence of the in-
volvement of Rev-erbs in metabolism is provided by
studies on heme, which has diverse biological func-
tions, including oxygen sensing, cell respiration, and
metabolism.136 Heme, whose expression occurs in a
circadianmanner,137 canbind tobothREV-ERBs.138
Heme binding to REV-ERBs facilitates recruitment
of the nuclear corepressor NCoR.133,138 The rate-
limiting enzyme in heme biosynthesis, aminolevuli-
nate synthase 1 (Alas1), is directly controlled by the
clock.139 Heme biosynthesis is also influenced by the
nutritional status through the regulation ofAlas1 by
the PPAR coactivator 1 (PGC-1).140 This nu-
clear receptor coactivator is induced by fasting140
and participates in a variety of metabolic pathways
such as glucose and lipid regulation.141 Moreover,
both PGC-1 and heme are able to modulate the
expression of circadian genes.137,142,143 These re-
sults illustrate how REV-ERBs can sense dynamic
metabolic changes and transmit them to the core
clock machinery.
PPARs are members of the nuclear hormone re-
ceptor superfamily of ligand-activated transcrip-
tion factors. The three PPARs (, , ) have been
shown to regulate carbohydrate, lipid, lipopro-
tein, and energy metabolism.144,145 Ppara is rhyth-
mically expressed in tissues with high fatty acid
catabolism rates such as the liver and adipose tis-
sue. Pparg is rhythmically expressed in liver and
WAT, while Ppard expression oscillates in liver and
brown adipose tissue (BAT).36 PPAR is likely to
play a role in connecting circadian physiology to
metabolism. Ppar-deficient mice (Ppara−/−) have
normal rhythmic behavior and clock gene expres-
sion in the SCN, but PPAR deficiency alters Bmal1
andPer3 expression in the liver.Moreover,Ppara de-
ficiency leads to disrupted phase resetting of Bmal1
when food is provided during the light period, in-
dicating that PPAR may control Bmal1. Indeed,
PPAR directly regulates hepatic Bmal1 expression
through a response element located in its pro-
moter.146 Besides, it has been shown that Ppara
is a clock-controlled gene147 and daytime feed-
ing inverts its circadian expression pattern in the
liver.146 Interestingly, PPAR is also connected to
the nuclear receptor Rev-erba because the PPAR
agonists (fibrates) induce liver expression of Rev-
erba. In addition, PPAR (as well as PPAR) can
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directly transactivate Rev-erba via RevDR2 located
in its promoter.92,132,148 Clearly, all these data
demonstrate that the metabolic sensor PPARmay
play a prominent role in circadian functioning.
Other results indicate that PER2 has the capacity to
recruit PPAR or REV-ERB for the modulation of
Bmal1 expression,96 again showing intimate inter-
actions between clock and metabolic components
in the clock circuitry.
PPAR and PPAR are both involved in energy
homeostasis. A recent study reveals that PER2 can
interact directly with PPAR to repress its tran-
scriptional activity. Ablation of Per2 in cell cul-
ture increased induction of adipogenic genes, while
deletion of Per2 in mice results in slight changes
in circadian expression of PPAR target genes in
WAT.87 These results demonstrate that the control
of PPAR by a circadian actor is essential for nor-
mal lipidmetabolism. Interestingly, PGC-1 (PPAR
coactivator 1, as introduced above), which is in-
volved in thermogenesis and associated metabolic
responses,142,149 is rhythmically expressed in phase
with Pparg , Ppard, and thermogenic genes, such as
Ucp1 and thyroid receptor  (Tra), in BAT.36 Fur-
thermore, PGC-1 can specifically bind PPAR ,149
whereas the latter can also interact with the Ucp1
promoter.150 All these data suggest that PPARs could
transmit (diurnal) changes in heat dissipation to the
circadian system.
These data suggest that nuclear receptors are con-
trolling anamazing arrayofmetabolic functions and
are capable of communicating the body’s metabolic
state to the core clockmachinery. Incidentally, other
nuclear receptor subgroups also participate in the
interplay between metabolic and circadian physiol-




The tight connection between the circadian tim-
ing system and metabolism is also underscored by
the role of nutrient sensors. Clock adaptation to
metabolic reactions is likely to be achieved also
by direct input of nutrient sensing regulators to
the intrinsic clock machinery. However, we are
aware that the subdivision between nuclear recep-
tors presented above and metabolic sensors that we
will introduce in this section may appear rather
arbitrary.
Recent evidence has demonstrated that local
changes in cellular energy, such as redox reac-
tions (portmanteau for reduction-oxidation), can
influence the circadian expression of core clock
genes and clock-related nuclear receptors. Nicoti-
namide adenine dinucleotide (NAD+) and its re-
duced form NADH are coenzymes found in all liv-
ing cells. NAD+ also exists in a phosphorylated
form NADP+ and can be reduced to NADPH.
NAD(P)+ and NAD(P)H are involved in cellular
redox reactions. Interestingly, CLOCK:BMAL1 and
NPAS2:BMAL1 heterodimers can sense intracellu-
lar redox status. TheDNA-binding activities of these
dimers are influenced by both reduced and oxi-
dized forms of NAD(H) and NADP(H) in an op-
posing manner. The reduced forms (NADH and
NADPH) activate DNA binding of CLOCK:BMAL1
and NPAS2:BMAL1, whereas the oxidized forms
(NAD+ and NADP+) inhibit it, consistent with a
role as redox sensors.152 These results raise the pos-
sibility that cell energy metabolism can influence
circadian rhythmicity. For example, these clock pro-
tein sensors might participate in the rhythm im-
posed by the alternation of fasting and feeding.
Indeed, NAD:NADH ratio is modified under fast-
ing and feeding conditions since starvation lowers
NADP:NADPH (i.e., shift toward a reduced state) in
both rat livermitochondria and cytoplasm.153 Thus,
for feeding synchronization, it is plausible that the
cellular redox status could transmit changes in en-
ergy metabolism directly to the clock architecture.
In this context, it is tempting to think that irregular
mealtimes could also contribute to circadian mis-
alignment by subtle perturbations of local circadian
oscillator functioning.
Sirtuin 1 (SIRT1), another energy sensor, has re-
cently been found to link circadian to metabolic
physiology. SIRT1 is a NAD-dependent histone
deacetylase that contributes to epigenetic gene si-
lencing and a plethora of biological processes rang-
ing from gluconeogenesis, insulin secretion and
sensitivity, lipid regulation, mitochondrial activity,
thermogenesis, adipogenesis and adipocyte differ-
entiation, and apoptosis. SIRT1 also plays a crucial
role in the caloric restriction-dependent life span
extension.154–156 SIRT1, whose expression occurs in
a circadian manner, has been shown to influence
circadian transcription of several clock genes (e.g.,
Per2, Cry1, Bmal1, and Rora).157 Moreover, SIRT1,
candirectly bindCLOCK:BMAL1heterodimers and
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promote deacetylation of PER2,157 BMAL1, and hi-
stone H3.158 Interestingly, SIRT1 can also affect ex-
pression of metabolic regulatory transcription fac-
tors. It can interact with and deacetylate PGC-1
to control the expression of gluconeogenic and gly-
colytic genes.159 In addition, hepatic SIRT1 is able to
modulate the expression of PPAR.160 Importantly,
SIRT1 can also repress the fat regulator PPAR and
it is activated during fasting to promote fat mobi-
lization inWAT, again demonstrating its clear impli-
cation in lipid homeostasis.161 Furthermore, SIRT1
has been shown to be decreased in adipose tissue
endothelial cells from obese human subjects.162 Of
interest, since fat accumulation is associated with
several adverse complications, such as diabetes and
hypertension, caloric restriction (and consequent
fat depletion) that has multiple biological and life-
extending benefits163 may be used to prevent or treat
metabolic disruptions.
In addition to NAD(P)+ and SIRT1, AMP-
activated protein kinase (AMPK) is a further im-
portant nutrient sensor. AMPK is sensitive to fluc-
tuations in the cellular AMP:ATP ratio and can be
activated by various factors such as exercise, glu-
cose deprivation, or leptin treatment. The func-
tions of AMPK cover the whole-body energy bal-
ance (e.g., food intake, bodymass, lipid and glucose
homeostasis, cholesterol and triglyceride synthe-
sis, energy expenditure).164 In mouse skeletal
muscle and cultured myotubes, AMPK has been
demonstrated to regulate genes involved in en-
ergy metabolism by acting in coordination with
SIRT1. Interestingly, AMPK activation increases
NAD+ levels, which in turn enhance SIRT1 ac-
tivity, resulting in the deacetylation and activation
of the downstream SIRT1 target PGC-1.165 Dele-
tion of the AMPK3 subunit in mice leads to im-
paired expression profiles of clock genes in skeletal
muscle in response to the AMPK activator AICAR
(5-amino-4-imidazole-carboxamide riboside), and
attenuated daily variations of the respiratory ex-
change ratio.166 AMPK also has direct actions on
the clock machinery. AMPK phosphorylates and
destabilizesCRY1.167 Casein kinase Iε, an important
regulator of PER proteins stability, is also phospho-
rylated by AMPK that induces subsequent degrada-
tion of PER2 and phase shifts of peripheral oscil-
lators.168 Recently, it has been demonstrated that
mice deficient for either AMPK1 or AMPK2
have altered circadian feeding behavior and free-
running periods.169 Surprisingly, the rhythmic gene
expression of leptin, PGC-1 and nicotinamide
phosphoryl-transferase (NAMPT), a rate-limiting
enzyme in the NAD+ salvage pathway regulated
by CLOCK:BMAL1,170,171 was abolished in AMPK-
deficient mice.169 This study reveals that AMPK
is to some extent involved in the cycling of the
NAMPT-(NAD+)-SIRT1-PGC-1 pathway. In ad-
dition, prolonged activation of SIRT1 by its agonist
SRT1720 causes an indirect activation of AMPK,
and both SIRT1 and AMPK respond to low-energy
levels.164,172 Therefore, SIRT1 and AMPKmay have
overlapping functions to ensure the fine tuning of
metabolic and clock regulations. Consequently, if
a drug exerts effects on these actors, it is advis-
able to also explore its influence on the core clock
machinery.
Finally, it is important to mention that the mam-
malian molecular circadian clockwork (based on
transcriptional–translational events) overviewed in
this section is not a unique cellular clock model.
Indeed, circadian redox rhythms of peroxiredoxins,
which are antioxidant enzymes, can occur indepen-
dently of transcription, thus defining a metabolic
nontranscriptional oscillator.173
Conclusion
At the molecular/cellular levels, the recent findings
cited above highlightmultiple transcriptional cross-
roads between circadian and metabolic pathways in
organs involved in metabolism, namely liver, adi-
pose tissue, pancreas, and muscle. Nuclear recep-
tors such as Rors and Rev-erbs are well situated to
receive metabolic signals and integrate them into
the core clock architecture. In addition, we show
that fluctuations in cellular metabolism can directly
influence the transcriptional activity of core clock
components such as Cry1, Per2, Clock, and Bmal1.
At the level of the organism, the circadian tim-
ing system provides internal temporal organization
controlled locally byperipheral clocks/oscillators re-
set by feeding time, and supervised by the master
SCN clock mainly reset by ambient light. Impair-
ment of this internal timing due to altered endoge-
nous clockwork ormisalignmentwith external cues,
light, and/or mealtime, has a deleterious impact on
metabolic health.
Overconsumption of “junk” (most often hyper-
caloric) food is a well-acknowledged causal factor of
obesity. In addition to the type and quantity of food
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eaten, we have reviewed here the importance of the
hour of the daywhen food is eaten. In short, it seems
that the recommendation of “doing the right thing
at the right time” is relevant for the relation between
food intake and circadian rhythmicity, in that sig-
nificant amounts of ingested fuels at the wrong cir-
cadian time (i.e., resting period) can predispose to
increased adiposity and other metabolic risks. This
link, together with the putative obesogenic property
of repeated light–dark shifts or chronic shift work,
leads to the concept that we called “chronobesity”.65
Furthermore,metabolic diseases are associatedwith
circadian disturbances in behavior and physiology,
not only in peripheral organs but also in the brain.
Together, these findings suggest thatmanagement of
circadian disorders is especially important in obese
and diabetic people to prevent a kind of vicious cir-
cle that could amplify health problems.
We propose that dietary strategies for limiting, or
preventing, overweight and obesity could be further
optimized by taking into account circadian rhyth-
micity tomaintain (or restore) normal temporal or-
ganization and synchronization to local time, that
is, by developing chronotherapeutic approaches of
dieting.
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